Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. (Q54354990)

28 May 2018

title

Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. (English)

1 reference

28 May 2018

main subject

virology

0 references

Cytomegalovirus

0 references

organ transplantation

1 reference

2

1 reference

28 May 2018

Eloisa Arbustini

12

1 reference

28 May 2018

author name string

G Gerna

1

1 reference

28 May 2018

A Chiesa

3

1 reference

28 May 2018

P Zelini

4

1 reference

28 May 2018

M Furione

5

1 reference

28 May 2018

G Comolli

6

1 reference

28 May 2018

C Pellegrini

7

1 reference

28 May 2018

E Sarchi

8

1 reference

28 May 2018

C Migotto

9

1 reference

28 May 2018

M Regazzi Bonora

10

1 reference

28 May 2018

F Meloni

11

1 reference

28 May 2018

language of work or name

English

0 references

publication date

9 August 2011

1 reference

28 May 2018

American Journal of Transplantation

published in

1 reference

28 May 2018

volume

11

1 reference

28 May 2018

issue

11

1 reference

28 May 2018

page(s)

2463-2471

1 reference

28 May 2018

Infection in organ-transplant recipients

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Prevention and treatment of cytomegalovirus infection in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Cellular immune responses to cytomegalovirus in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

De novoTherapy with Everolimus, Low‐Dose Ciclosporine A, Basiliximab and Steroid Elimination in Pediatric Kidney Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Quantification of Cytomegalovirus DNA in BAL Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

Preemptive Therapy for Systemic and Pulmonary Human Cytomegalovirus Infection in Lung Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2011.03636.X

10.1111/J.1600-6143.2011.03636.X

21 January 2018

Identifiers

DOI

1 reference

28 May 2018

release_rng7puk47jak3k2vedmq4jervy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rng7puk47jak3k2vedmq4jervy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

28 May 2018